Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Cepton, Inc. (NASDAQ: CPTN) Solidifies Its Detroit Presence with New Office in Troy; Poised to Be Integral Part of Latest Auto Trends

Cepton has opened a new dedicated automotive office in Metro Detroit – a clear sign of its growing relationship with General Motors and the American auto industry Company solidifies itself as a key player in lidar; Metro Detroit office serves as automotive hub providing local support to OEM and Tier 1 partners Cepton boasts collaboration […]

Homing Peptides: Silo Pharma Inc. (SILO) Targets ADRs

Silo’s partnership with UMB could yield therapeutics that limit side effects through precisely targeted delivery On February 3, 2022, Silo Pharma (OTCQB: SILO) extended its research partnership with the University of Maryland, Baltimore (“UMB”) to explore potentially lifesaving joint-homing peptides that target inflamed endothelium (a thin membrane that lines the inside of the heart and […]

Emerging iGaming Technology Trends Fuel Golden Matrix Group Inc.’s (NASDAQ: GMGI) B2B Growth Strategy

Enhanced graphics, Gamification, AI-powered loyalty systems and data analytics redefining iGaming experience and generating higher player yields for online operators. GMGI sets industry standard, offers 10,000+ games across 25+ providers Company provides highly configurable, modular, white-label, turnkey gaming platforms compatible with all major operating systems, browsers, devices Company recently reported 221% Q2-2022 growth, 15 consecutive […]

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Reports Growth, Ongoing Optimism for Natural Food Brands Amid Market Pressures

Plant-based foods investment company Eat Well Investment Group Inc. has positioned itself to respond to global food needs exacerbated by the COVID pandemic and the war in Ukraine, and it reports its subsidiaries are in the right place to help deal with food sector concerns Eat Well recently announced its annual financial data and Q1 […]

GeoSolar Technologies Inc. Is ‘One to Watch’

GeoSolar Technologies is focused on revolutionizing the way we heat, cool and power homes with 100% natural energy sources The company’s technology has been installed in multiple test homes in Colorado and achieved exceptional results The GeoSolarPlus system combines solar power, geothermal ground-sourced energy and other clean energy technologies into one fully integrated system The […]

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Technology Enhances Bioavailability of Orally Administered APIs

Lexaria is a global innovator in drug delivery platforms The company has developed the patented DehydraTECH(TM) technology that significantly improves the bioavailability of orally administered pharmaceuticals and therapeutics Bioavailability is the fraction of a drug that reaches the site of action or systemic circulation While drugs delivered intravenously are 100% bioavailable, drugs that have any […]

Odyssey Health, Inc.’s (ODYY) Sports Advisory Board Enhancing Public Awareness and Understanding of Traumatic Brain Injuries

Odyssey’s Sports Advisory Board (“SAB”) was formed in 2021 to enhance public awareness of traumatic brain injuries and concussion The board’s members – Abby Wambach, Kurt Warner, and Brett Favre – have had storied careers in their respective sports and have expressed hope that scientists will examine their brains after their death to advance their […]

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Expands Patient Eligibility for Brain Cancer Drug Trial, Receives Approval from U.S. FDA for Protocol Amendment

Novel brain cancer drug developer CNS Pharmaceuticals, Inc. has received approval from the U.S. FDA for a Protocol Amendment that expands patient eligibility for participation in its potentially pivotal Phase 2 clinical trial for a novel drug candidate that targets the nearly 100 percent fatal cancer glioblastoma (“GBM”) CNS is developing the drug candidate Berubicin […]

 

From Our Blog

Wrap Technologies Inc. (NASDAQ: WRAP) Positions Non-Lethal Innovation at the Center of Public Safety Reform

August 7, 2026

Across the United States, a quiet but consequential shift is underway in how communities approach public safety. Rather than treating equipment, training and accountability as separate priorities, agencies are increasingly seeking integrated systems that connect the tools officers carry with the training that prepares them and the data that documents every encounter. This full-stack approach […]

Rotate your device 90° to view site.